Lonza Group AG (LONN) CHF1 (Regd)

Sell:590.60 CHFBuy:590.80 CHF11.80 CHF (2.04%)

Prices delayed by at least 15 minutes
Sell:590.60 CHF
Buy:590.80 CHF
Change:11.80 CHF (2.04%)
Prices delayed by at least 15 minutes
Sell:590.60 CHF
Buy:590.80 CHF
Change:11.80 CHF (2.04%)
Prices delayed by at least 15 minutes

Company Information

About this company

Lonza Group AG (Lonza) is a Switzerland-based holding company and a supplier to the pharmaceutical, healthcare and life science industries. The Company's offerings include custom development and manufacturing of drugs and drug delivery systems, as well as development of anti-microbial solutions for commercial applications. The Company divides its activities into two segments: Pharma&Biotech and Specialty Ingredients. The Pharma&Biotech comprises the Company's Biologics, Small-Molecule, and Consumables and Research Tools businesses. The segment includes mammalian, microbial, chemical, bioconjugates, cell and gene therapy technology platforms. The Specialty Ingredients segment focuses on anti-microbial applications within Consumer Health division, which covers hygiene, nutrition and personal care products, as well as preservatives, capsules and food supplements, among others, and Consumer & Resources Protection division, which includes coatings and composites, and agro ingredients.

Key people

Wolfgang Wienand
Chief Executive Officer
Philippe Deecke
Chief Financial Officer, Member of the Executive Committee
Ulrike Kaeppler
Chief Human Resource Officer, Member of the Executive Committee
Gordon Bates
President - Small Molecules, Member of the Executive Committee
Jean-Christophe Hyvert
President - Biologics, Member of the Executive Committee
Maria Soler Nunez
Member of the Executive Committee, Head, Group Operations
Daniel Palmacci
Member of the Executive Committee, President, Cell & Gene
Christian Seufert
Member of the Executive Committee, President, Capsules & Health Ingredients Division
Jean-Marc Huet
Chairman of the Board
Christoph Maeder
Lead Independent Vice Chairman of the Board
Marion Helmes
Independent Member of the Board
Angelica Kohlmann
Independent Member of the Board
Roger M. Nitsch
Independent Member of the Board
Click to see more

Key facts

  • EPIC
    -
  • Location
    Switzerland
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    CH0013841017
  • Market cap
    CHF 41.82bn
  • Employees
    18,686
  • Shares in issue
    72.23m
  • Exchange
    SIX Swiss Exchange
  • Index
    Swiss Market Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.